Search hospitals

>

California

>

Los Angeles

Cedars-Sinai Medical Center

Claim this profile

Los Angeles, California 90048

Global Leader in Cancer

Global Leader in Breast Cancer

Conducts research for Lung Cancer

Conducts research for Solid Tumors

Conducts research for Pancreatic Cancer

1450 reported clinical trials

171 medical researchers

Photo of Cedars-Sinai Medical Center in Los AngelesPhoto of Cedars-Sinai Medical Center in Los AngelesPhoto of Cedars-Sinai Medical Center in Los Angeles

Summary

Cedars-Sinai Medical Center is a medical facility located in Los Angeles, California. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Solid Tumors, Pancreatic Cancer and other specialties. Cedars-Sinai Medical Center is involved with conducting 1,450 clinical trials across 1,614 conditions. There are 171 research doctors associated with this hospital, such as Leo Mascarenhas, MD, Fataneh (Fae) Majlessipour, Saibal Kar, MD, and Raj Makkar.

Area of expertise

1

Cancer

Global Leader

Cedars-Sinai Medical Center has run 186 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage III
HER2 negative
2

Breast Cancer

Global Leader

Cedars-Sinai Medical Center has run 99 trials for Breast Cancer. Some of their research focus areas include:

HER2 negative
Stage IV
ER positive

Top PIs

Clinical Trials running at Cedars-Sinai Medical Center

Skin Cancer

Breast Cancer

Cancer

Lung Cancer

Breast cancer

Crohn's Disease

Kidney Cancer

Non-Hodgkin's Lymphoma

Ovarian Cancer

Prostate Cancer

Image of trial facility.

Cemiplimab + Surgery

for Advanced Skin Cancer

This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.

Recruiting

2 awards

Phase 3

7 criteria

Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Cedars-Sinai Medical Center?

Where is Cedars-Sinai Medical Center located?

Who should I call to ask about financial aid or insurance network?

What insurance does Cedars-Sinai Medical Center accept?

What awards or recognition has Cedars-Sinai Medical Center received?